Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
Colloquium Life sciences in society

Colloquium Life sciences in society

What have we learned after 40 years of debate (...)

Competition for the Environment, Agronomy and (...)

Competition for the Environment, Agronomy and Industry

The leading biotech and biotherapy cluster

The leading biotech and biotherapy cluster

Genopole's Business Support

Genopole’s Business Support

Our real estate offer

Our real estate offer

Synthetic and systems biology

Synthetic and systems biology

A medical environment

A medical environment

Genobiomedecine, a path toward personalized treatments

Genobiomedecine, a path toward personalized treatments

Consult our latest key figures for 2013

Consult our latest key figures for 2013

Year 2013 marked the history of the biocluster in

Agenda

29.09

EMBO Conference on Innate Lymphoid Cells

The study of Innate Lymphoid Cells (ILCs) is a strong emergent field in immunology that is having a major impact on our understanding of the early events unfolding during an immune response. (...)

Read more

24.09

BioSpain 2014

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (2.775) and companies (...)

Read more

06.06

Worldviews and Values in Synthetic Biology

The workshop “Worldviews and Values in Synthetic Biology”, co-organised by Paris Sorbonne University and Freiburg University aims to identify the various views and values associated to synthetic (...)

Read more

05.06

Biovision 2014

BIOVISION leverages a unique multi-stakeholder approach with the opportunity for innovation projects and initiative holders to meet, connect and build collaborative networks with potential (...)

Read more

Live news

  • Global Bioenergies on track with the development schedule of its bio-isobutene production process

    Global Bioenergies, an industrial biology company developing sustainable routes to light olefins, announces significant progress in the development of its process for the production of biological (...)

  • Gene Signal and collaborators demonstrate successful activity of topical aganirsen

    Gene Signal announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drop) in two important models of retinal neovascular disease, wet age-related (...)